Study Finds GLP-1 Medications Significantly Reduce Mortality in Colon Cancer Patients
A groundbreaking study conducted by researchers at the University of California San Diego has unveiled compelling evidence suggesting that glucagon-like peptide-1 (GLP-1) receptor agonists—widely recognized...
















